|
시장보고서
상품코드
1874361
세계의 정액 분석 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)Semen Analysis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 |
||||||
QYResearch
세계의 정액 분석 시장 규모는 2024년에 1,680만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 8.6%로 성장하여 2031년까지 2,990만 달러로 확대될 것으로 예측됩니다.
정액 분석(정액 검사라고도 함)은 남성의 정액과 그 안에 포함된 정자의 특정 특성을 평가하는 것입니다. 임신을 원하는 분들의 남성 불임 평가와 정관수술의 성공 여부 확인 등에 도움을 드리기 위해 시행합니다. 정액 검사(정자수 검사라고도 함)는 남성의 정자 건강 상태와 생존력을 분석합니다. 정액은 사정 시 방출되는 정자(및 기타 당질 및 단백질 물질)를 함유한 액체입니다. 정액 검사는 정자의 건강 상태와 관련된 세 가지 주요 요소, 즉 정자 수, 정자 모양, 정자 운동성(정자 운동성)의 세 가지 요소를 측정합니다.
정액 검사 시장은 꾸준히 성장하고 있습니다. 이는 전 세계적으로 남성 불임의 유병률이 증가하고 있으며, 전 세계 남성의 약 7-12%가 영향을 받고 있기 때문입니다. 생식 건강에 대한 인식이 높아짐에 따라 더 많은 부부가 의학적 평가를 요청하고 있으며, 정액 검사는 남성 불임 평가의 기초가 되고 있습니다. 자동 정액 분석기의 발전으로 수동 현미경 검사에 비해 빠르고 정확하며 표준화된 결과를 얻을 수 있어 불임 클리닉, 병원, 연구시설에서 도입 확대가 촉진되고 있습니다. 또한 체외수정(IVF), 인공수정(IUI) 등 생식보조의료기술(ART)의 보급이 확대되면서 정자의 질을 정밀하게 평가하고자 하는 수요가 증가하고 있습니다. 새롭게 등장한 가정용 정액 검사 키트와 스마트폰 기반 분석 솔루션도 특히 프라이버시와 편리함을 추구하는 젊은 층과 기술에 정통한 소비자층을 중심으로 시장 접근성을 확대하고 있습니다. 또한, 선진국 시장에서의 불임 진단에 대한 정부 지원과 보험 적용 범위 확대도 성장을 견인하고 있습니다.
수요는 견조하지만 정액 분석 시장은 성장을 저해할 수 있는 여러 가지 문제에 직면해 있습니다. 주요 문제 중 하나는 검사 방법 및 장비의 표준화가 미흡하여 결과에 편차가 발생하여 임상적 판단을 복잡하게 만드는 점입니다. 수동 분석은 많은 지역, 특히 중저소득 국가에서 여전히 일반적이지만, 시간이 많이 걸리고 인위적인 실수가 발생하기 쉬우며 운영자에게 크게 의존합니다. 자동화 시스템을 도입하더라도 제조업체 간 교정, 알고리즘, 기준값의 차이가 비교 가능성을 제한합니다. 또한, 남성 불임에 대한 문화적 편견과 사회적 금기는 특히 보수적인 사회에서 남성 불임 진단을 받는 것을 방해하는 요인으로 작용하고 있습니다. 규제적 장벽과 보험 환급의 제한도 첨단 시스템 및 재택 검사 장비의 보급 확대에 걸림돌로 작용하고 있습니다. 마지막으로, 전 세계 많은 지역에서 숙련된 기술자와 배아배양사공급이 제한되어 있어 종합적인 불임 진단 서비스 제공에 제약이 되고 있습니다.
이 보고서는 정액 분석 세계 시장에 대한 종합적인 분석을 제공하는 것을 목표로 합니다. 총매출액, 주요 기업의 시장 점유율과 순위에 초점을 맞추고, 지역별, 국가별, 유형별, 용도별 정액 분석을 함께 분석합니다.
정액 분석 시장 규모, 추정치 및 예측은 2024년을 기준 연도로 하여 2020년에서 2031년까지의 과거 데이터와 예측 데이터를 포함하는 매출 수익으로 제시되었습니다. 정량적 분석과 정성적 분석을 통해 독자들이 정액 분석 관련 사업/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 자사 포지셔닝 분석, 정보에 입각한 사업적 판단을 할 수 있도록 돕습니다.
시장 세분화
기업별
- Medical Electronics System
- CooperSurgical
- Hamilton Thorne
- FertiPro
- Sperm Processor
- Microptic
- DNA Diagnostic Center
- Princeton BioMeditech
- Proiser R+D
- MotilityCount
- Bioline Technologies
- Sandstone Diagnostics
유형별 부문
- 분석 장비
- 시약 및 키트
용도별 부문
- 병원 및 불임치료 클리닉
- 재택치료
지역별
- 북미
- 미국
- 캐나다
- 아시아태평양
- 중국
- 일본
- 한국
- 동남아시아
- 인도
- 호주
- 기타 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 네덜란드
- 북유럽 국가
- 기타 유럽
- 라틴아메리카
- 멕시코
- 브라질
- 기타 라틴아메리카
- 중동 및 아프리카
- 튀르키예
- 사우디아라비아
- 아랍에미리트(UAE)
- 기타 중동 및 아프리카
자주 묻는 질문
The global market for Semen Analysis was estimated to be worth US$ 16.8 million in 2024 and is forecast to a readjusted size of US$ 29.9 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
A semen analysis, also called "seminogram" evaluates certain characteristics of a male's semen and the sperm contained therein. It is done to help evaluate male fertility, whether for those seeking pregnancy or verifying the success of vasectomy. Semen analysis, also known as a sperm count test, analyses the health and viability of a man's sperm. Semen is the fluid containing sperm (plus other sugar and protein substances) that's released during ejaculation. A semen analysis measures three major factors of sperm health: the number of sperm the shape of the sperm the movement of the sperm, also known as "sperm motility".
The semen analysis market is growing steadily, driven by the rising global prevalence of male infertility, which affects approximately 7-12% of men worldwide. As awareness of reproductive health increases, more couples are seeking medical evaluation, and semen analysis remains the cornerstone of male fertility assessment. Advances in automated semen analyzers, which offer faster, more accurate, and standardized results compared to manual microscopy, are encouraging broader adoption in fertility clinics, hospitals, and research laboratories. Furthermore, the growing popularity of assisted reproductive technologies (ART)-such as in vitro fertilization (IVF) and intrauterine insemination (IUI)-is generating increased demand for precise sperm quality assessments. Emerging at-home semen testing kits and smartphone-based analysis solutions are also expanding market access, particularly among younger and tech-savvy consumers seeking privacy and convenience. In addition, increasing government support and insurance coverage for infertility diagnostics in developed markets is helping to fuel further growth.
Despite strong demand, the semen analysis market faces several challenges that could hinder its expansion. One major issue is the lack of standardization across testing methodologies and equipment, which leads to variability in results and can complicate clinical decision-making. Manual analysis remains common in many regions, particularly in low- and middle-income countries, but it is time-consuming, prone to human error, and highly operator-dependent. Even with automated systems, differences in calibration, algorithms, and reference values among manufacturers limit comparability. Additionally, cultural stigma and social taboos around male infertility often discourage men from seeking diagnosis, particularly in conservative societies. Regulatory hurdles and reimbursement limitations also pose obstacles for widespread adoption of advanced systems and at-home testing devices. Lastly, limited availability of skilled technicians and embryologists in many parts of the world further restricts the implementation of comprehensive fertility diagnostic services.
This report aims to provide a comprehensive presentation of the global market for Semen Analysis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Semen Analysis by region & country, by Type, and by Application.
The Semen Analysis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Semen Analysis.
Market Segmentation
By Company
- Medical Electronics System
- CooperSurgical
- Hamilton Thorne
- FertiPro
- Sperm Processor
- Microptic
- DNA Diagnostic Center
- Princeton BioMeditech
- Proiser R+D
- MotilityCount
- Bioline Technologies
- Sandstone Diagnostics
Segment by Type
- Analyzers
- Reagents and Kits
Segment by Application
- Hospitals and Fertility Clinics
- Home Care
By Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Semen Analysis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Semen Analysis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Semen Analysis in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 Semen Analysis Product Introduction
- 1.2 Global Semen Analysis Market Size Forecast (2020-2031)
- 1.3 Semen Analysis Market Trends & Drivers
- 1.3.1 Semen Analysis Industry Trends
- 1.3.2 Semen Analysis Market Drivers & Opportunity
- 1.3.3 Semen Analysis Market Challenges
- 1.3.4 Semen Analysis Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global Semen Analysis Players Revenue Ranking (2024)
- 2.2 Global Semen Analysis Revenue by Company (2020-2025)
- 2.3 Key Companies Semen Analysis Manufacturing Base Distribution and Headquarters
- 2.4 Key Companies Semen Analysis Product Offered
- 2.5 Key Companies Time to Begin Mass Production of Semen Analysis
- 2.6 Semen Analysis Market Competitive Analysis
- 2.6.1 Semen Analysis Market Concentration Rate (2020-2025)
- 2.6.2 Global 5 and 10 Largest Companies by Semen Analysis Revenue in 2024
- 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Semen Analysis as of 2024)
- 2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 Analyzers
- 3.1.2 Reagents and Kits
- 3.2 Global Semen Analysis Sales Value by Type
- 3.2.1 Global Semen Analysis Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Semen Analysis Sales Value, by Type (2020-2031)
- 3.2.3 Global Semen Analysis Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
- 4.1 Introduction by Application
- 4.1.1 Hospitals and Fertility Clinics
- 4.1.2 Home Care
- 4.2 Global Semen Analysis Sales Value by Application
- 4.2.1 Global Semen Analysis Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Semen Analysis Sales Value, by Application (2020-2031)
- 4.2.3 Global Semen Analysis Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
- 5.1 Global Semen Analysis Sales Value by Region
- 5.1.1 Global Semen Analysis Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Semen Analysis Sales Value by Region (2020-2025)
- 5.1.3 Global Semen Analysis Sales Value by Region (2026-2031)
- 5.1.4 Global Semen Analysis Sales Value by Region (%), (2020-2031)
- 5.2 North America
- 5.2.1 North America Semen Analysis Sales Value, 2020-2031
- 5.2.2 North America Semen Analysis Sales Value by Country (%), 2024 VS 2031
- 5.3 Europe
- 5.3.1 Europe Semen Analysis Sales Value, 2020-2031
- 5.3.2 Europe Semen Analysis Sales Value by Country (%), 2024 VS 2031
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Semen Analysis Sales Value, 2020-2031
- 5.4.2 Asia Pacific Semen Analysis Sales Value by Region (%), 2024 VS 2031
- 5.5 South America
- 5.5.1 South America Semen Analysis Sales Value, 2020-2031
- 5.5.2 South America Semen Analysis Sales Value by Country (%), 2024 VS 2031
- 5.6 Middle East & Africa
- 5.6.1 Middle East & Africa Semen Analysis Sales Value, 2020-2031
- 5.6.2 Middle East & Africa Semen Analysis Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions Semen Analysis Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions Semen Analysis Sales Value, 2020-2031
- 6.3 United States
- 6.3.1 United States Semen Analysis Sales Value, 2020-2031
- 6.3.2 United States Semen Analysis Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Semen Analysis Sales Value by Application, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Semen Analysis Sales Value, 2020-2031
- 6.4.2 Europe Semen Analysis Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Semen Analysis Sales Value by Application, 2024 VS 2031
- 6.5 China
- 6.5.1 China Semen Analysis Sales Value, 2020-2031
- 6.5.2 China Semen Analysis Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Semen Analysis Sales Value by Application, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan Semen Analysis Sales Value, 2020-2031
- 6.6.2 Japan Semen Analysis Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Semen Analysis Sales Value by Application, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea Semen Analysis Sales Value, 2020-2031
- 6.7.2 South Korea Semen Analysis Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Semen Analysis Sales Value by Application, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia Semen Analysis Sales Value, 2020-2031
- 6.8.2 Southeast Asia Semen Analysis Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Semen Analysis Sales Value by Application, 2024 VS 2031
- 6.9 India
- 6.9.1 India Semen Analysis Sales Value, 2020-2031
- 6.9.2 India Semen Analysis Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Semen Analysis Sales Value by Application, 2024 VS 2031
7 Company Profiles
- 7.1 Medical Electronics System
- 7.1.1 Medical Electronics System Profile
- 7.1.2 Medical Electronics System Main Business
- 7.1.3 Medical Electronics System Semen Analysis Products, Services and Solutions
- 7.1.4 Medical Electronics System Semen Analysis Revenue (US$ Million) & (2020-2025)
- 7.1.5 Medical Electronics System Recent Developments
- 7.2 CooperSurgical
- 7.2.1 CooperSurgical Profile
- 7.2.2 CooperSurgical Main Business
- 7.2.3 CooperSurgical Semen Analysis Products, Services and Solutions
- 7.2.4 CooperSurgical Semen Analysis Revenue (US$ Million) & (2020-2025)
- 7.2.5 CooperSurgical Recent Developments
- 7.3 Hamilton Thorne
- 7.3.1 Hamilton Thorne Profile
- 7.3.2 Hamilton Thorne Main Business
- 7.3.3 Hamilton Thorne Semen Analysis Products, Services and Solutions
- 7.3.4 Hamilton Thorne Semen Analysis Revenue (US$ Million) & (2020-2025)
- 7.3.5 Hamilton Thorne Recent Developments
- 7.4 FertiPro
- 7.4.1 FertiPro Profile
- 7.4.2 FertiPro Main Business
- 7.4.3 FertiPro Semen Analysis Products, Services and Solutions
- 7.4.4 FertiPro Semen Analysis Revenue (US$ Million) & (2020-2025)
- 7.4.5 FertiPro Recent Developments
- 7.5 Sperm Processor
- 7.5.1 Sperm Processor Profile
- 7.5.2 Sperm Processor Main Business
- 7.5.3 Sperm Processor Semen Analysis Products, Services and Solutions
- 7.5.4 Sperm Processor Semen Analysis Revenue (US$ Million) & (2020-2025)
- 7.5.5 Sperm Processor Recent Developments
- 7.6 Microptic
- 7.6.1 Microptic Profile
- 7.6.2 Microptic Main Business
- 7.6.3 Microptic Semen Analysis Products, Services and Solutions
- 7.6.4 Microptic Semen Analysis Revenue (US$ Million) & (2020-2025)
- 7.6.5 Microptic Recent Developments
- 7.7 DNA Diagnostic Center
- 7.7.1 DNA Diagnostic Center Profile
- 7.7.2 DNA Diagnostic Center Main Business
- 7.7.3 DNA Diagnostic Center Semen Analysis Products, Services and Solutions
- 7.7.4 DNA Diagnostic Center Semen Analysis Revenue (US$ Million) & (2020-2025)
- 7.7.5 DNA Diagnostic Center Recent Developments
- 7.8 Princeton BioMeditech
- 7.8.1 Princeton BioMeditech Profile
- 7.8.2 Princeton BioMeditech Main Business
- 7.8.3 Princeton BioMeditech Semen Analysis Products, Services and Solutions
- 7.8.4 Princeton BioMeditech Semen Analysis Revenue (US$ Million) & (2020-2025)
- 7.8.5 Princeton BioMeditech Recent Developments
- 7.9 Proiser R+D
- 7.9.1 Proiser R+D Profile
- 7.9.2 Proiser R+D Main Business
- 7.9.3 Proiser R+D Semen Analysis Products, Services and Solutions
- 7.9.4 Proiser R+D Semen Analysis Revenue (US$ Million) & (2020-2025)
- 7.9.5 Proiser R+D Recent Developments
- 7.10 MotilityCount
- 7.10.1 MotilityCount Profile
- 7.10.2 MotilityCount Main Business
- 7.10.3 MotilityCount Semen Analysis Products, Services and Solutions
- 7.10.4 MotilityCount Semen Analysis Revenue (US$ Million) & (2020-2025)
- 7.10.5 MotilityCount Recent Developments
- 7.11 Bioline Technologies
- 7.11.1 Bioline Technologies Profile
- 7.11.2 Bioline Technologies Main Business
- 7.11.3 Bioline Technologies Semen Analysis Products, Services and Solutions
- 7.11.4 Bioline Technologies Semen Analysis Revenue (US$ Million) & (2020-2025)
- 7.11.5 Bioline Technologies Recent Developments
- 7.12 Sandstone Diagnostics
- 7.12.1 Sandstone Diagnostics Profile
- 7.12.2 Sandstone Diagnostics Main Business
- 7.12.3 Sandstone Diagnostics Semen Analysis Products, Services and Solutions
- 7.12.4 Sandstone Diagnostics Semen Analysis Revenue (US$ Million) & (2020-2025)
- 7.12.5 Sandstone Diagnostics Recent Developments
8 Industry Chain Analysis
- 8.1 Semen Analysis Industrial Chain
- 8.2 Semen Analysis Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 Semen Analysis Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Semen Analysis Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.1.1 Methodology/Research Approach
- 10.2 Author Details
- 10.3 Disclaimer
